tissue solutions limited Company Information
Company Number
SC331666
Next Accounts
126 days late
Shareholders
the intelligent tissue group limited
Group Structure
View All
Industry
Other human health activities
Registered Address
cypex ltd 6 tom mcdonald avenue, dundee, DD2 1NH
Website
www.tissue-solutions.comtissue solutions limited Estimated Valuation
Pomanda estimates the enterprise value of TISSUE SOLUTIONS LIMITED at £2.4m based on a Turnover of £3.9m and 0.61x industry multiple (adjusted for size and gross margin).
tissue solutions limited Estimated Valuation
Pomanda estimates the enterprise value of TISSUE SOLUTIONS LIMITED at £4.2m based on an EBITDA of £908.8k and a 4.67x industry multiple (adjusted for size and gross margin).
tissue solutions limited Estimated Valuation
Pomanda estimates the enterprise value of TISSUE SOLUTIONS LIMITED at £222.1m based on Net Assets of £89.1m and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Tissue Solutions Limited Overview
Tissue Solutions Limited is a live company located in dundee, DD2 1NH with a Companies House number of SC331666. It operates in the other human health activities sector, SIC Code 86900. Founded in October 2007, it's largest shareholder is the intelligent tissue group limited with a 100% stake. Tissue Solutions Limited is a established, small sized company, Pomanda has estimated its turnover at £3.9m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Tissue Solutions Limited Health Check
Pomanda's financial health check has awarded Tissue Solutions Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 1 areas for improvement. Company Health Check FAQs
6 Strong
4 Regular
1 Weak
Size
annual sales of £3.9m, make it larger than the average company (£820k)
£3.9m - Tissue Solutions Limited
£820k - Industry AVG
Growth
3 year (CAGR) sales growth of 17%, show it is growing at a faster rate (4.7%)
- Tissue Solutions Limited
4.7% - Industry AVG
Production
with a gross margin of 39.2%, this company has a comparable cost of product (36.4%)
39.2% - Tissue Solutions Limited
36.4% - Industry AVG
Profitability
an operating margin of 22.8% make it more profitable than the average company (7%)
22.8% - Tissue Solutions Limited
7% - Industry AVG
Employees
with 16 employees, this is similar to the industry average (19)
16 - Tissue Solutions Limited
19 - Industry AVG
Pay Structure
on an average salary of £25.5k, the company has an equivalent pay structure (£25.5k)
- Tissue Solutions Limited
£25.5k - Industry AVG
Efficiency
resulting in sales per employee of £246k, this is more efficient (£49.6k)
£246k - Tissue Solutions Limited
£49.6k - Industry AVG
Debtor Days
it gets paid by customers after 22 days, this is near the average (23 days)
22 days - Tissue Solutions Limited
23 days - Industry AVG
Creditor Days
its suppliers are paid after 75 days, this is slower than average (17 days)
75 days - Tissue Solutions Limited
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Tissue Solutions Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 4 weeks, this is less cash available to meet short term requirements (106 weeks)
4 weeks - Tissue Solutions Limited
106 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5.4%, this is a lower level of debt than the average (27.5%)
5.4% - Tissue Solutions Limited
27.5% - Industry AVG
TISSUE SOLUTIONS LIMITED financials
Tissue Solutions Limited's latest turnover from December 2022 is £3.9 million and the company has net assets of £89.1 million. According to their latest financial statements, Tissue Solutions Limited has 16 employees and maintains cash reserves of £467.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Apr 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 3,936,541 | ||||||||||||||
Other Income Or Grants | 0 | ||||||||||||||
Cost Of Sales | 2,393,524 | ||||||||||||||
Gross Profit | 1,543,017 | ||||||||||||||
Admin Expenses | 645,237 | ||||||||||||||
Operating Profit | 897,780 | ||||||||||||||
Interest Payable | 0 | ||||||||||||||
Interest Receivable | 0 | ||||||||||||||
Pre-Tax Profit | 897,780 | ||||||||||||||
Tax | 1,530 | ||||||||||||||
Profit After Tax | 899,310 | ||||||||||||||
Dividends Paid | 0 | ||||||||||||||
Retained Profit | 899,310 | ||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 16 | 14 | 14 | 14 | 21 | 14 | 13 | 10 | |||||||
EBITDA* | 908,804 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Apr 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 19,559 | 18,775 | 4,776 | 10,848 | 17,169 | 38,203 | 16,799 | 12,059 | 7,370 | 13,219 | 14,579 | 9,264 | 2,983 | 4,005 | 3,520 |
Intangible Assets | 16,555 | 16,587 | 16,500 | 16,916 | 18,583 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 52,311,947 | 0 | 0 | 86 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 565,730 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 52,348,061 | 35,362 | 21,276 | 27,850 | 35,752 | 38,203 | 16,799 | 12,059 | 573,100 | 13,219 | 14,579 | 9,264 | 2,983 | 4,005 | 3,520 |
Stock & work in progress | 0 | 0 | 0 | 113,562 | 95,995 | 56,775 | 62,609 | 50,865 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 246,878 | 660,109 | 1,020,481 | 812,298 | 781,499 | 918,932 | 672,336 | 647,425 | 347,196 | 440,957 | 344,571 | 228,140 | 71,571 | 124,176 | 87,615 |
Group Debtors | 7,534,394 | 2,075,918 | 300,556 | 30,790 | 0 | 1,211,782 | 849,572 | 650,040 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 33,608,993 | 378,123 | 244,100 | 332,302 | 151,063 | 93,660 | 28,364 | 16,819 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 467,110 | 632,622 | 2,071,901 | 1,489,970 | 828,171 | 2,117,076 | 1,688,222 | 605,351 | 150,131 | 445,392 | 360,789 | 182,536 | 132,960 | 83,032 | 28,171 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 41,857,375 | 3,746,772 | 3,637,038 | 2,778,922 | 1,856,728 | 4,398,225 | 3,301,103 | 1,970,500 | 497,327 | 886,349 | 705,360 | 410,676 | 204,531 | 207,208 | 115,786 |
total assets | 94,205,436 | 3,782,134 | 3,658,314 | 2,806,772 | 1,892,480 | 4,436,428 | 3,317,902 | 1,982,559 | 1,070,427 | 899,568 | 719,939 | 419,940 | 207,514 | 211,213 | 119,306 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 495,426 | 384,032 | 684,206 | 673,057 | 457,904 | 692,924 | 390,132 | 321,521 | 293,278 | 337,574 | 334,812 | 186,075 | 123,952 | 144,254 | 70,234 |
Group/Directors Accounts | 4,347,760 | 9,368 | 237,718 | 121,010 | 8,194 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 270,840 | 419,220 | 546,896 | 395,149 | 409,066 | 560,331 | 468,450 | 405,373 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 5,114,026 | 812,620 | 1,468,820 | 1,189,216 | 875,164 | 1,253,255 | 858,582 | 726,894 | 293,278 | 337,574 | 334,812 | 186,075 | 123,952 | 144,254 | 70,234 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 3,017 | 2,158 | 844 | 5,017 | 5,615 | 5,387 | 3,024 | 2,171 | 1,474 | 2,644 | 2,916 | 1,853 | 597 | 801 | 689 |
total long term liabilities | 3,017 | 2,158 | 844 | 5,017 | 5,615 | 5,387 | 3,024 | 2,171 | 1,474 | 2,644 | 2,916 | 1,853 | 597 | 801 | 689 |
total liabilities | 5,117,043 | 814,778 | 1,469,664 | 1,194,233 | 880,779 | 1,258,642 | 861,606 | 729,065 | 294,752 | 340,218 | 337,728 | 187,928 | 124,549 | 145,055 | 70,923 |
net assets | 89,088,393 | 2,967,356 | 2,188,650 | 1,612,539 | 1,011,701 | 3,177,786 | 2,456,296 | 1,253,494 | 775,675 | 559,350 | 382,211 | 232,012 | 82,965 | 66,158 | 48,383 |
total shareholders funds | 89,088,393 | 2,967,356 | 2,188,650 | 1,612,539 | 1,011,701 | 3,177,786 | 2,456,296 | 1,253,494 | 775,675 | 559,350 | 382,211 | 232,012 | 82,965 | 66,158 | 48,383 |
Dec 2022 | Dec 2021 | Apr 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 897,780 | ||||||||||||||
Depreciation | 10,992 | 4,876 | 4,062 | 10,159 | 9,475 | 8,613 | 3,967 | 5,733 | 5,849 | 6,345 | 4,726 | 2,745 | 3,370 | 2,854 | 1,704 |
Amortisation | 32 | 8 | 416 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | 1,530 | ||||||||||||||
Stock | 0 | -113,562 | -113,562 | 17,567 | 39,220 | -5,834 | 11,744 | 50,865 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 38,276,115 | 1,938,760 | 389,747 | 242,828 | -1,291,812 | 674,102 | 235,988 | 401,358 | 471,969 | 96,386 | 116,431 | 156,569 | -52,605 | 36,561 | 87,615 |
Creditors | 111,394 | -289,025 | 11,149 | 215,153 | -235,020 | 302,792 | 68,611 | 28,243 | -44,296 | 2,762 | 148,737 | 62,123 | -20,302 | 74,020 | 70,234 |
Accruals and Deferred Income | -148,380 | 24,071 | 151,747 | -13,917 | -151,265 | 91,881 | 63,077 | 405,373 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 859 | -2,859 | -4,173 | -598 | 228 | 2,363 | 853 | 697 | -1,170 | -272 | 1,063 | 1,256 | -204 | 112 | 689 |
Cash flow from operations | -37,401,908 | ||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 52,311,947 | -86 | -86 | 86 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 4,338,392 | -111,642 | 116,708 | 112,816 | 8,194 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | 0 | ||||||||||||||
cash flow from financing | 89,560,119 | ||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -165,512 | -857,348 | 581,931 | 661,799 | -1,288,905 | 428,854 | 1,082,871 | 455,220 | -295,261 | 84,603 | 178,253 | 49,576 | 49,928 | 54,861 | 28,171 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -165,512 | -857,348 | 581,931 | 661,799 | -1,288,905 | 428,854 | 1,082,871 | 455,220 | -295,261 | 84,603 | 178,253 | 49,576 | 49,928 | 54,861 | 28,171 |
tissue solutions limited Credit Report and Business Information
Tissue Solutions Limited Competitor Analysis
Perform a competitor analysis for tissue solutions limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in DD2 area or any other competitors across 12 key performance metrics.
tissue solutions limited Ownership
TISSUE SOLUTIONS LIMITED group structure
Tissue Solutions Limited has no subsidiary companies.
Ultimate parent company
BIOIVT LLC
#0169546
2 parents
TISSUE SOLUTIONS LIMITED
SC331666
tissue solutions limited directors
Tissue Solutions Limited currently has 8 directors. The longest serving directors include Mr Miguel Tobin (Apr 2021) and Mr Piyush Shukla (Oct 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Miguel Tobin | Scotland | 39 years | Apr 2021 | - | Director |
Mr Piyush Shukla | Scotland | 48 years | Oct 2021 | - | Director |
Mr Piyush Shukla | England | 48 years | Oct 2021 | - | Director |
Mr Adam Friedman | Scotland | 34 years | Oct 2021 | - | Director |
Mr Adam Friedman | Scotland | 34 years | Oct 2021 | - | Director |
Mr Richard Haigh | Scotland | 56 years | Sep 2022 | - | Director |
Mr Andrea Romoli | United States | 51 years | Jun 2023 | - | Director |
Ms Laurie Fuller | United Kingdom | 58 years | Jun 2023 | - | Director |
P&L
December 2022turnover
3.9m
0%
operating profit
897.8k
0%
gross margin
39.2%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
89.1m
+29.02%
total assets
94.2m
+23.91%
cash
467.1k
-0.26%
net assets
Total assets minus all liabilities
tissue solutions limited company details
company number
SC331666
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
October 2007
age
18
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
December 2022
previous names
N/A
accountant
MAZARS LLP
auditor
-
address
cypex ltd 6 tom mcdonald avenue, dundee, DD2 1NH
Bank
HSBC BANK PLC
Legal Advisor
-
tissue solutions limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to tissue solutions limited.
tissue solutions limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TISSUE SOLUTIONS LIMITED. This can take several minutes, an email will notify you when this has completed.
tissue solutions limited Companies House Filings - See Documents
date | description | view/download |
---|